MADRID, 16 Abr. (EUROPE PRESS) –
The President of the Commission on Biological Magnitudes Relating to the Medical Emergency Department of the Spanish Society of Laboratory Medicine (SEQCML), Dr. Luis García of Guadiana Romualdo, has been honoring the paper of the pandemic laboratory medicine, ” contribute to the identification of patients as well as high risk of progression, and are also used for the establishment of outpatient treatment strategies, thus reducing the assisted living facilities in hospitals and the monitoring of the course of the child.
In the same vein, the Vice-President of the Spanish Society of Laboratory Medicine, Dr. Antonio Buño, since the first time the clinical laboratory has been “key piece” in the correct organization of assistance. “From the diagnosis of the median infection to the detection of viruses in the respiratory tract samples have the necessary tests for the correct, prognostic and helpful correction in the field of therapeutic decisions, the clinical laboratory is in a very basic situation “, señala.
Ambos experts, together with the member of the Committee of Laboratory Medicine Based on the Evidence of the SEQCML, Dr. Daniel Morell García, participant in the month organized by dicha Sociedad ‘Aportation of laboratory medicine in the pandemic COVID-19’ en el marko del 2º Congreso Nacional Multidisciplinar COVID-19 de las Sociedades Sientíficas en España.
BIOCOVID REGISTER
The BIOCOVID registry is an example of the work and implication of Spain’s laboratory professionals during the pandemic. As explained by Dr. Morell García, this registry is an initiative of the professionals of laboratory medicine that surges with the idea of ”identifying numbers of laboratory tests that are included in the principle of pandemic in the analytical profiles of these eran patients actually use to identify precautionary measures to the patients of burgemeester riesgo “.
In addition, it also implements an objective second, transmitting to the physicians the importance of knowing the analytical methods used for the treatment of these tests, given the variability that can be given in the function of the assay that is used to perform an analysis.
El estudio BIOCOVID has the most important results for the manejo del COVID-19. As a result, I have described as useful 4 habitat parameters of the laboratories (creatinine, troponin, protein C reactive and recuento of plaques) for the establishment of the prognosis of patients COVID-19.
Asimismo, a sub-study has allowed to demonstrate the potential interests of the use of stratified court points for sex for the tropics with the end of increasing the detection capacity of the myocardial donor associated with a prognostic peer. In addition, an ultimate objective is to obtain a median classification of ‘machine-learning’ techniques, combining laboratory tests and other variables, in order to establish the prognosis of the COVID-19 patient included in the Emergency Services.
NEW MARKETS FOR THE PROVINCE OF THE PATIENT COVID-19
These are the number of studies that will try to find new biomarkers useful for the assessment of the risk of infected patients with SARS-CoV-2. “Initial dates of the second year have been demonstrated that some marketers have tried their hand at the first one, like the dimer D of the interval 6 (IL-6), has not been compared to the second mode in the second, and is probably necessary. “Contra with new markets that precede the inflammation and thrombosis, characteristics of the more severe forms”, says doctor García de Guadiana.
“In addition, the laboratory medicine must be able to treat herramines that allow the evolution of COVID-19 patients to be improved during the agitation phase”, states this expert. In this sense, marketers like KL-6 (Krebs von den Lugen), with known prognostic value in interstitial pulmonary disease, can be used in the detection of pulmonary fibrosis as possible sequelae of disease.
LABORATORY SERVICE IN CAMPAÑA HOSPITALS
“The organization and adaptation in time record and with enormous difficulties to cover in the hospital hospitals that he created as support for the existing ones is clear master of the implication of the clinical professionals in this sanitary crisis”, han señalado en su ponencia.
This is the case of IFEMA Hospital, created as an emergency measure to improve an emergency situation in the first instance affecting the Community of Madrid in the third week of March 2020. “The coronavirus epidemic has exploded in a very crowded place In terms of time and the capacity to attend patients in the emergency services, there is no shortage of facilities for the centers and they have all the resources that can be established in their area, and these facilities are limited to a maximum of 2,500 patients suffering from ingress “, explains doctor Buño.
To cover the needs of IFEMA’s laboratory tests and in emergencies with the habit that they have all organized, opt for ‘in situ’ an infrastructure that allows them to organize the samples, receive the petitions and send them to the laboratory from the University Hospital La Paz is located 8 kilometers away.
During the entire period in which the COVID-19 IFEMA Hospital was established, a total of 4,933 analyzes were performed on 1,985 patients with a total of 88,022 samples in addition to 1,151 POCT gasometers.
There are many similarities in the organization model of the Hospital for Emergencies and Pandemics Isabel Zendal with the IFEMA Campaign Hospital, although there are also many differences, explains Doctor Buño. “While respecting the laboratory, the organizational model is the same, it is said, the samples are extracted several times in a pre-analysis area and are prepared to be sent to the laboratories of Hospital La Paz. Mediante programs are transport, its analyzes and results are integrated in the hospital information systems.
There are examples of hospitals that support the rest of the health centers of the Community of Madrid in different scenarios of this pandemic. “In both cases, the laboratory has to organize and adapt rapidly to cover patients’ needs,” said the vice president of the Spanish Laboratory of Laboratory Medicine.
As well as Dr. Buño, the laboratory medicine has sustained a high impact on the COVID-19 pandemic, claiming to have important reasons for adjusting circuits, protocols and plants, as well as assisting the patient in the contact of our companions; review security procedures in the laboratory and in some cases learn to utilize specific individual protection teams; increase formation in this new nosological entity; help interpret laboratory test results and amplify laboratory areas to service existing demand; participate in active form in the laboratory’s access to the patient’s cab.